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Abstract
This paper introduces a cure rate survival model by assuming that the time to the event of interest
follows a beta prime distribution and that the number of competing causes of the event of interest
follows a negative binomial distribution. This model provides a novel alternative to the existing
cure rate regression models due to its flexibility, as the beta prime model can exhibit greater levels
of skewness and kurtosis than those of the gamma and inverse Gaussian distributions. Moreover,
the hazard rate of this model can have an upside-down bathtub or an increasing shape. We ap-
proach both parameter estimation and local influence based on likelihood methods. In special,
three perturbation schemes are considered for local influence. Numerical evaluation of the pro-
posed model is performed by Monte Carlo simulations. In order to illustrate the potential for
practice of our model we apply it to a real data set.
Keywords Beta prime distribution; Likelihood methods; Local influence; Long-term survival
model; Medical data; Negative binomial distribution.
1 Introduction
In medical and epidemiological studies, often interest focuses on studying the effect of concomitant
information on the time to event such as death or recurrence of a disease. When the primary inter-
est is to estimate the covariate effect, the Cox proportional hazards model is commonly used in the
analysis of survival time data; see Cox (1972). With the development of medical and health sciences,
the datasets collected from clinical studies pose some new challenges to statisticians. New statistical
models which can incorporate these changes should be investigated. The most prevalent change noted
in many clinical studies is that, more patients respond favorably to a treatment or, were not susceptible
to the event of interest in the study, so they are considered cured or have prolonged disease-free sur-
vival. This proportion of patients is called the cure fraction. Incorporating the cure fraction in survival
models leads to cure rate models or long-term survival models. These models have been widely devel-
oped in the biostatistics literature. Historically, one of the most famous cure rate models is the mix-
ture cure model introduced by Berkson and Gage (1952). This model has been extensively discussed
by several authors, including Farewell (1982), Maller and Zhou (1996), Ewell and Ibrahim (1997),
Stangl and Greenhouse (1998) and Calsavara et al (2013). Later, Yakovlev and Tsodikov (1996) and
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Chen et al. (1999) proposed the promotion time cure model or bounded cumulative hazard model in
cancer relapse settings, assuming that a latent biological process of propagation of latent carcino-
genic tumor cells is generating the observed failure (relapse). Recently, Cooner et al. (2007) general-
ized this framework to a flexible class of cure models under latent activation schemes, Cancho et al.
(2011) proposed a flexible cure rate model, which encompasses as special cases the mixture model
(Berkson and Gage, 1952), the promotion time cure model (Chen et al., 1999), and the cure rate pro-
portional odds model proposed by Gu et al. (2011). The statistical literature for modeling lifetime data
in the presence of a cure fraction and latent competing causes is vast and growing rapidly. Interested
readers can refer to Yakovlev and Tsodikov (1996), Tsodikov et al. (2003), Yin and Ibrahim (2005),
Cooner et al. (2007), Castro et al. (2009), Rodrigues et al. (2009), Cancho et al. (2012), Borges et al.
(2012), among others.
In this context, our main objective is to introduce the negative binomial beta prime (NBBP) cure
rate model, conceived inside a latent competing causes scenario with cure fraction, where there is no
information about which cause was responsible for the individual death or tumor recurrence, but only
the minimum lifetime value among all risks is observed and a part of the population is not susceptible
to the event of interest. The beta prime model has properties that its competitor distributions of the
exponential family do not have. For example, the hazard rate function of beta prime distribution can
have an upside-down bathtub or increasing shape depending on the parameter values. Most classical
two-parameter distributions such as Weibull and gamma distributions have monotone hazard rate
functions. The skewness and kurtosis of the beta prime distribution can be much larger than those
of the gamma and inverse Gaussian distributions, which may be more appropriate in certain practical
situations.
The rest of this paper is organized as follows. In Section 2, we introduce the proposed long-term
survival model and discuss some of its properties as well as some special models. The estimation
method for the model parameters is discussed in Section 3. In Section 4, we illustrate the proposed
model through simulation and an application to medical real-world data set. In Section 5, we mention
some concluding remarks.
2 The negative binomial beta prime regression model with cure
rate
In this section we will formulate the NBBP regression model with cure rate. The ingredients of the
proposed model are: (i) the unified long-term survival model used formulated by Rodrigues et al.
(2009); (ii) the BP distribution for modeling the time to the event of interest; and (iii) the NB distri-
bution for modeling the number of competing causes of the event of interest.
Let N denote the number of competing causes related to the occurrence of an event of interest,
for an individual in the population. Conditional on N , we assume that the Zj’s are independent and
identically distributed random variables representing the promotion times of the competing causes,
for j = 1, . . . , n. Moreover, we assume that N is independent of Z1, . . . , Zn and the observable
time-to-event is defined as T = min{Z1, . . . , ZN} for N ≥ 1, and T = ∞ if N = 0, which leads to
a cured fraction denoted by p0; see Rodrigues et al. (2009). Under this setup, the long-term survival
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function (SF) of the random variable T is given by
Sp(t|·) = P(T ≥ t) = P(N = 0) +
∞∑
n=1
P(Z1 > t, . . . , ZN > t|N = n)P(N = n)
=
∞∑
n=0
P(N = n)[ST (t|·)]
n = AN(ST (t|·)), t > 0, (1)
where ST (·|·) denotes the SF of the unobserved lifetimes and AN (·) is the probability generating
function of the random variable N , which converges when ST (t|·) ∈ [0, 1]. Various results can be
obtained for each choice of AN (·) and ST (·|·) considered in (1).
A random variable X follows the beta prime (BP) distribution with shape parameters α > 0 and
β > 0, if its cumulative distribution function (CDF) and probability density function (PDF) are given
by
FX(x|α, β) = Ix/(1+x)(α, β), (2)
and
fX(x|α, β) =
xα−1(1 + x)−(α+β)
B(α, β)
,
where Iy(α, β) = By(α, β)/B(α, β) is the incomplete beta function ratio, By(α, β) =
∫ y
0
uα−1(1 −
u)β − 1du is the incomplete function, B(α, β) = Γ(α)Γ(β)/Γ(α + β) is the beta function and
Γ(α) =
∫∞
0
uα−1 exp(−u)du is the gamma function. The BP is related with several models. The
interested reader in BP model is referred to Bourguignon et al. (2018); McDonald and Butler (1990);
McDonald (1987, 1984) and Johnson et al. (1995). These works present reviews and generalizations
of BP model. In this context, to introduced the negative binomial beta prime (NBBP) model, we
are considering the parameterization used in Bourguignon et al. (2018), where the PDF of the BP
distribution is given by
fBP(t|µ, φ) =
tµ(φ+1)−1(1 + t)−[µ(φ+1)+φ+2]
B(µ(φ+ 1), φ+ 2))
, (3)
where α = µ(φ + 1) and β = φ + 2. In this case, the BP distribution is indexed by in terms of the
mean (µ) and precision parameters (φ).
Consider that the number of competing causes N follows a NB distribution (particular cases are
the Poisson, binomial , Bernoulli and geometric distributions) with parameters α and θ, for θ > 0 and
α θ > −1, and that the time to the event of interest is BP distributed with parameters µ and φ as in
(3). Then, the long-term SF of cured patients is given by
Sp(t|ξ) = [1 + α θFBP(t|µ, φ)]
−1/α , t > 0, (4)
where ξ = (α, θ, µ, φ)⊤. The corresponding PDF and HR obtained from (4) are respectively ex-
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pressed as
fp(t|ξ) =
θtµ(φ+1)−1(1 + t)−[µ(φ+1)+φ+2]
B(µ(φ+ 1), φ+ 2)
[1 + α θFBP(t|µ, φ)]
−1/α−1 ,
hp(t|ξ) =
θtµ(φ+1)−1(1 + t)−[µ(φ+1)+φ+2]
B(µ(φ+ 1), φ+ 2)
[1 + α θFBP(t|µ, φ)]
−1 , t > 0.
The SF for the non-cured population (or NBBP SF), denoted by SNBBP, is given by
SNBBP(t|ξ) =
[1 + α θFBP(t|µ, φ)]
−1/α − (1 + α θ)−1/α
1− (1 + α θ)−1/α
, t > 0. (5)
From (5) we have lim
t→0
SNBBP(t|ξ) = 1 and lim
t→+∞
SNBBP(t|ξ) = 0, so SNBBP is a proper SF. The
PDF of non-cured population (or NBBP PDF), denoted by fNBBP(t|ξ) is given by
fNBBP(t|ξ) =
θfBP(t|µ, φ) [1 + α θFBP(t|µ, φ)]
−(1+1/α)
1− (1 + α θ)−1/α
, t > 0. (6)
3 Estimation and Diagnostics
Here, we use the maximum likelihood (ML) method to estimate the model parameters. We as-
sume that the time to event is not completely observed and is subject to right censoring. We observe
ti = min{yi, ci} and δi = I(yi ≤ ci), where ci is the censoring time, and δi = 1 if yi it is time to
the event and δi = 0 if it is right censored, for i = 1, . . . , n. Then, from n pairs of times and censor-
ing indicators, (y1, δ1), . . . , (y1, δn) say, the corresponding likelihood function, under uninformative
censoring, is given by
L(ϑ|y) =
n∏
i=1
[fpop(yi|ϑ)]
δi[Spop(yi|ϑ)]
1−δi, (7)
where ϑ = (ξ,β)⊤,
Spop(yi|ξ,β) =


[1 + (p−α0i − 1)FBP(yi|ξ)]
−1/α, if α 6= 0;
p
FBP(yi|ξ)
0i , if α = 0,
(8)
and
fpop(yi|ξ,β) =


[1 + (p−α0i − 1)FBP(yi|ξ)]
−1/α−1
(
p−α0i −1
α
)
fBP(yi|ξ), if α 6= 0;
− log (p0i) p
FBP(yi|ξ)
0i fBP(yi|ξ), if α = 0,
(9)
with log[p0i/(1 − p0i)] = x
⊤
i β, that is, p0i =
exp(x⊤i β)
1+exp(x⊤i β)
, i = 1, . . . , n, where β is the vector of
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regression coefficients. Therefore, covariates are used to estimate the cured fraction (p0).
From (8)-(9), the likelihood function in (7) is expressed as
L(ϑ|y) =


∏n
i=1
[(
p−α0i −1
α
)
fBP(yi|ξ)
]δi
[1 + (p−α0i − 1)FBP(yi|ξ)]
−δi−1/α, if α 6= 0;
∏n
i=1[− log (p0i) fBP(yi|ξ)
δi]p
FBP(yi|ξ)
0i , if α = 0.
(10)
The ML estimators will be obtained using numerical methods, since equating the first-order log-
likelihood derivatives to zero leads us to a complicated system of nonlinear equations. It can be easily
performed by using standard non-linear maximization procedures found in most of statistical and data
analysis packages.
In order to assess the sensitivity of the ML estimators to atypical cases, we perform local influence
analysis which is based on the curvature of the log-likelihood function. Recall that ϑ = (ξ,β)⊤ and
let the vector of perturbations ω be a subset of Ω ∈ Rm, whereas ω0 is a non-perturbation vector such
that ℓ(ϑ|ω0) = ℓ(ϑ) = log(L(ϑ)), for all ϑ. Then, the likelihood distance (LD) is given by LD(ϑ) =
2(ℓ(ϑ̂) − ℓ(ϑ̂ω)), where ϑ̂ω is the ML estimate of ϑ under the perturbed model, and the normal
curvature for ϑ̂, at the direction vector d (||d|| = 1), is given by Cd(ϑ̂) = 2|d
⊤
∇
⊤
Σ(ϑ̂)−1∇d|,
where ∇ is a (q + 3) × m matrix that depends on the perturbation scheme, whose elements are
∇ji = ∂
2ℓ(ϑ|ω)/∂ϑj∂ωi, evaluated at ϑ = ϑ̂ and ω = ω0, for j = 1, . . . , q + 3 and i = 1, . . . , m;
see ?. Index plot of the eigenvector dmax associated with the maximum eigenvalue of B(ϑ) =
−∇⊤Σ(ϑ)−1∇, Cdmax(ϑ) say, evaluated at ϑ = ϑ̂ and ω = ω0, can indicate cases which have a
high influence on LD(ϑ). Moreover, the vector di = ein can be considered to detect local influence,
where eim denotes an m × 1 vector of zeros with one at the ith position. Thus, the corresponding
normal curvature takes the form Ci(ϑ) = 2|bii(ϑ)|, where bii(ϑ) is the ith diagonal element ofB(ϑ),
for i = 1, . . . , m, evaluated at ϑ = ϑ̂ and ω = ω0. Then, the case i is potentially influential if
Ci(ϑ̂) >
2
m
∑m
i=1Ci(ϑ̂). In this paper, we consider the following perturbation schemes: case-weight,
response and explanatory variable; see Cook (1987).
4 Numerical applications
This section presents a simulation study to evaluate the performance of the ML estimators of the
model parameters and an application to a real-world medical data set regarding a study on cutaneous
melanoma (a type of malignant cancer), for the evaluation of postoperative treatment performance
by means of a high dose of a certain drug (interferon alfa-2b) for the prevention of recurrence. The
patients in this study were added from 1991 to 1995 with a follow-up of 3 years; see Ibrahim et al.
(2001).
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4.1 A simulation study
We carry out a Monte Carlo (MC) simulation study to evaluate the performance of the ML es-
timators for the proposed model. The simulation scenario considers the following: sample sizes
n ∈ {200, 400, 600, 800, 1000}, µ = {0.50, 1.00}, σ = {1.00, 10.00} and 5,000 MC replications.
The cured fraction is p0i = exp(b0 + b1xi)/[1 + exp(b0 + b1xi)]. For the simulations, we consider a
binary covariate x with values drawn from a Bernoulli distribution with parameter 0.5. We consider
b0 = 0.50 and b1 = −1.00 such that the cure fraction for the two levels of x are p00 = 0.62 and
p01 = 0.38, respectively. The censoring times were samples from the uniform distribution, U(a, b),
where a, b > 0 were set in order to control the proportion of censored observations. In our study, the
proportion of censored observations was on the average obtained for the each sample size; see Ta-
ble 1. Note that, based on the probability integral transform, the NBBP model CDF follows a U(0, 1)
distribution. Then, the NBBP SF is U(0, 1) distributed as well. Random number generation from the
NBBP model is performed following Algorithm 1. In step #2 of this algorithm, we use the function
uniroot of the R software to get the root of the equation; see Brent (1973). For each value of the
parameter, sample size and censoring proportion, we report the empirical values for the bias and mean
squared error (MSE) of the ML estimators in Table 1. From this table, note that, as the sample size
increases, the ML estimators become more efficient, as expected.
Algorithm 1 Generator of random numbers from the NBBP model.
1: Fix the parameters values;
2: Obtain a random number of the covariate x fromX ∼ Bernoulli(1, 1/2), V ∼ U(0, 1) andW ∼ U(p0j , 1),
j = {0, 1};
3: LetXi = j. If vi < p0j , t =∞, otherwise
[1 + (p−α0i − 1)FBP (yi|ξ)]
−1/α = wi,
and
p
FBP (yi|ξ)
0i = wi,
if α 6= 0 and α = 0, respectively;
4: Extract the censored time ci from C ∼ U(a, b), for a, b > 0 fixed;
5: Compute ti = min{yi, ci};
6: If yi < ci, then δi = 1, otherwise δi = 0;
7: Repeat Steps 1 to 6 until the required number of data has been generated.
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Table 1: empirical mean and SD of the ML estimators of cure fractions for simulated data from the
NBBP model.
n (censoring %)
EM
µ̂ φ̂ α̂ β̂0 β̂1 p̂00 p̂01
True Values → 0.500 1.000 2.000 0.500 −1.000 0.623 0.377
200 (52.98%) 0.5441 1.3714 2.4005 0.4410 −1.0482 0.6076 0.3571
(0.3381) (1.2152) (1.5111) (0.2334) (0.2928) (0.8946) (0.5843)
400 (52.63%) 0.5381 1.1324 2.1477 0.4781 −1.0324 0.6169 0.3598
(0.2103) (0.7293) (0.9810) (0.1598) (0.2061) (0.5929) (0.3764)
600 (51.83%) 0.5298 1.0981 2.1247 0.4521 −1.0290 0.6109 0.3615
(0.1554) (0.5518) (0.7656) (0.1263) (0.1664) (0.4603) (0.2912)
800 (51.72%) 0.5203 1.0777 2.1129 0.4698 −1.0224 0.6152 0.3654
(0.1220) (0.4531) (0.6628) (0.1069) (0.1426) (0.4021) 0.2560
1000 (51.85%) 0.5186 1.0587 2.0571 0.4708 −1.0083 0.6154 0.3686
(0.1103) (0.3999) (0.5986) (0.0953) (0.1269) (0.3631) (0.2331)
200 (65.85%) 1.1006 11.5546 2.5208 0.4488 −1.1013 0.6099 0.3526
(0.2953) (4.1330) (1.9962) (0.3050) (0.3637) (1.1864) (0.7663)
400 (64.12%) 1.0700 10.1602 2.3147 0.4553 −1.0250 0.6108 0.3630
(0.1843) (2.4199) (1.3223) (0.1996) (0.2449) (0.7813) (0.5991)
600 (63.65%) 1.0697 10.0805 2.1491 0.4570 −1.0177 0.6120 0.3637
(0.1393) (1.9024) (1.0618) (0.1566) (0.1966) (0.6286) (0.4134)
800 (63.49%) 1.0480 10.0697 2.1451 0.4724 −1.0141 0.6157 0.3638
(0.1110) (1.6047) (0.8821) (0.1337) (0.1709) (0.5263) (0.3399)
1000 (62.98%) 1.0260 10.0331 2.0233 0.4853 −1.0059 0.6175 0.3657
(0.0907) (1.0790) (0.7557) (0.1163) (0.1510) (0.4556) (0.2930)
True Values → 1.000 10.000 2.000 0.500 −1.000 0.623 0.377
4.2 Application
The proposed model is now used to analyse a real-world data set corresponding to survival times of
n = 417 patients; see Lea˜o et al. (2018). This data set presents 56% of censored observations. The
covariates associated with each patient, i = 1, . . . , 417, are:
• ti: time (in years);
• xi1: treatment with 0 for observation and 1 for interferon);
• xi2: age (in years);
• xi3: nodule (nodule category: 1 to 4);
• xi4: sex (0 for male and 1 for female);
• xi5: p.s. (performance status-patient’s functional capacity scale as regards his daily activities:
0 for fully active and 1 for other); and
• xi6: tumor (tumor thickness inmm).
The interest here lies in the effects of these covariates on the cure fraction. Table 2 presents the esti-
mates of the parameters and their respective standard errors for the mixture cure Beta-Prime (MBP)
7
and NBBP cure rate regression models. Note that we consider the NBBP regression model with all
covariates, but only the covariate xi3, which represents nodule category, was significant. Since the
values of the Akaike information criterion (AIC) and Bayesian information criterion (BIC) are smaller
for the NBBP model compared with those values of the MBP model, this new distribution seems to
be a very competitive model for these data.
Table 2: ML estimate (SE in parentheses) and selection criteria to different models.
Parameter
MBP NBBP
MLE SE p-value MLE SE p-value
α − − − 2.778 1.075 −
µ 3.858 0.599 − 3.693 0.539 −
φ 2.085 0.514 − 2.054 0.279 −
β0 2.159 0.802 0.007 −0.873 2.345 0.709
β1 −0.179 0.273 0.510 −0.076 0.115 0.505
β2 −0.021 0.011 0.059 −0.008 0.005 0.158
β3 −1.382 0.488 0.004 −0.616 0.290 0.033
β4 0.260 0.278 0.349 0.056 0.134 0.675
β5 −0.171 0.417 0.682 −0.114 0.166 0.489
β6 −0.116 0.078 0.138 −0.017 0.019 0.396
AIC 1049.353 1045.886
BIC 1086.650 1084.217
Figure 1 displays the QQ-plots of the normalized randomized quantile residuals (each point cor-
responds to the median of five sets of ordered residuals) and the fitted SFs for nodal category based
on the Kaplan-Meier (KM) estimator, for the NBBP and MBP regression models. From this figure,
observe that the models are quite similar in terms of the fitted SFs, however the residuals show better
agreement in the NBBP model, which corroborates the results in Table 2.
Index plots of Ci under case-weight perturbation are shown in Figure 2. We omit the plots cor-
responding to response and covariate (tumor thickness, xi6) perturbations as they look very similar.
Note that the cases #88, #174, #247 and #279 are detected as potential influential observations under
the considered perturbation schemes.
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(c) QQ-MBP
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(d) SF-MBP
Figure 1: (a) QQ plot (a) and fitted KM (b) for the NBBP model and QQ plot (c) and fitted KM (d)
for the MBP model.
We assess the impact of the detected influential cases on the model inference with the relative
change (RC), which is obtained by removing influential cases and re-estimating the parameters and
their corresponding SEs. The RCs in the parameter estimates and their corresponding estimated
SEs are shown in Table 3. Also, p-values from the associated t-test are shown for the regression
coefficients. From this table, note that, in general, the largest RCs are related to the removal of the
case #279. Moreover, inferential changes are found only on β̂3.
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Figure 2: Index plots of Ci for α (left), ξ = (µ, φ)
⊤ (center) and β (right) with case-weight perturba-
tion and melanoma data.
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Table 3: RC (in %) in ML estimates and their corresponding SEs, and respective p-values in brackets;
inferential changes are highlighted in gray.
Dropped case(s) µ̂ φ̂ α̂ β̂0 β̂1 β̂2 β̂3 β̂4 β̂5 β̂6
{#88} RCζj(i) 8.43 96.25 291.90 239.44 828.98 2.75 25.82 76.24 52.64 49.07
RCSE(ζj(i)) (22.5) (89.45)(68.62) (70.95) (63.17) (31.01) (17.62) (51.32)(45.19) (65.20)
p-value - - - [0.651] [0.567] [0.112] [0.014] [0.692][0.644] [0.380]
{#174} RCζj(i) 6.66 94.60 294.73 210.75 765.32 2.31 23.34 62.06 57.02 46.90
RCSE(ζj(i))(15.29)(63.43)(53.87)(318.64) (62.41) (22.69) (87.72) (31.16)(42.17) (58.56)
p-value - - - [0.883] [0.601] [0.347] [0.264] [0.654][0.690] [0.442]
{#247} RCζj(i) 8.27 96.79 296.26 254.46 851.30 10.69 27.28 77.23 51.78 51.58
RCSE(ζj(i))(23.07)(94.10) (69.8) (11.08) (63.76) (38.67) (33.98) (53.16)(46.06) (66.21)
p-value - - - [0.440] [0.551] [0.101] [0.003] [0.693][0.632] [0.390]
{#279} RCζj(i) 2.00 96.60 344.63 241.57 974.54 21.37 29.49 84.83 64.33 53.94
RCSE(ζj(i))(14.49)(91.94)(66.35) (30.25) (65.03) (40.43) (30.21) (54.36)(48.88) (67.54)
p-value - - - [0.546] [0.485] [0.137] [0.005] [0.787][0.708] [0.394]
{#88,#174} RCζj(i) 6.74 94.47 289.13 207.90 638.35 7.46 23.58 64.44 82.37 46.37
RCSE(ζj(i))(17.64)(70.43)(59.41)(235.80) (62.28) (8.05) (52.74) (38.93)(43.81) (60.66)
p-value - - - [0.858] [0.656] [0.263] [0.171] [0.636][0.866] [0.413]
{#88,#247} RCζj(i) 8.50 95.93 286.03 237.18 715.64 3.52 26.04 78.82 76.54 49.76
RCSE(ζj(i))(22.91)(89.24)(68.60) (62.84) (62.78) (30.47) (17.90) (51.16)(44.61) (64.84)
p-value - - - [0.639] [0.618] [0.118] [0.013] [0.724][0.820] [0.391]
{#88,#279} RCζj(i) 2.26 95.61 334.19 225.00 872.31 15.32 28.42 86.32 87.94 52.77
RCSE(ζj(i))(15.41)(87.55)(65.23) (60.46) (64.20) (33.73) (16.65) (52.61)(47.48) (66.35)
p-value - - - [0.665] [0.537] [0.150] [0.018] [0.814][0.902] [0.399]
{#174,#247} RCζj(i) 6.25 90.13 277.20 169.98 658.18 6.10 19.87 60.76 80.13 45.66
RCSE(ζj(i)) (3.08) (24.97)(17.79)(413.55) (59.30) (88.09) (190.72) (1.31) (38.08) (41.98)
p-value - - - [0.939] [0.672] [0.525] [0.451] [0.746][0.863] [0.574]
{#174,#279} RCζj(i) 6.84 11.90 36.39 92.60 1490.16 75.48 46.58 10.56 73.46 84.34
RCSE(ζj(i)) (4.92) (22.66)(29.10) (44.67) (2.80) (28.98) (79.37) (10.18) (9.86) (41.56)
p-value - - - [0.459] [0.758] [0.125] [0.025] [0.418][0.897] [0.434]
{#247,#279} RCζj(i) 10.52 28.55 3.76 56.10 1261.59 75.14 33.02 21.34 86.37 52.08
RCSE(ζj(i))(11.44)(34.82)(36.27) (48.27) (3.90) (43.15) (69.34) (9.97) (4.45) (16.19)
p-value - - - [0.558] [0.783] [0.168] [0.031] [0.478][0.944] [0.432]
{#88,#174,#247} RCζj(i) 6.71 95.29 288.71 223.04 528.73 3.58 25.44 68.78 107.75 48.64
RCSE(ζj(i))(22.09)(88.18)(68.81) (56.75) (62.65) (29.07) (17.01) (50.43)(44.40) (64.81)
p-value - - - [0.662] [0.702] [0.100] [0.014] [0.609][0.940] [0.381]
{#88,#174,#279} RCζj(i) 0.19 93.91 334.44 198.78 689.95 5.89 26.61 75.03 119.53 50.44
RCSE(ζj(i))(12.92)(76.44)(59.99)(125.73) (63.56) (16.19) (17.10) (47.06)(46.21) (64.07)
p-value - - - [0.808] [0.622] [0.206] [0.086] [0.701][0.845] [0.408]
{#174,#247,#279} RCζj(i) 18.47 46.79 15.35 59.59 2261.28 93.71 49.00 36.77 19.45 80.57
RCSE(ζj(i))(33.76)(69.75)(60.28) (18.49) (7.41) (40.15) (81.51) (13.25)(25.73) (10.75)
p-value - - - [0.454] [0.596] [0.119] [0.024] [0.554][0.610] [0.328]
{#88,#174,#247,#279}RCζj(i) 21.12 49.09 34.49 46.31 2013.96 86.00 52.86 19.98 59.35 127.67
RCSE(ζj(i))(30.85)(13.59) (8.92) (230.86) (54.93) (113.29)(368.31)(10.23)(43.73)(245.70)
p-value - - - [0.806] [0.779] [0.326] [0.372] [0.555][0.879] [0.692]
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5 Concluding remarks
In this paper, we proposed a new model for survival data assuming competing causes of the event
of interest follows the negative binomial distribution and the time to event follow a BP distribution.
Estimation was approached by the maximum likelihood method. Diagnostic tools have been ob-
tained to detect locally influential observations in the maximum likelihood estimates. A Monte Carlo
simulation study was carried out to evaluate the behavior of the proposed model parameters. In the
application to a medical real-world data set, we observed that the new cure rate model delivers the
best fit. We hope the proposed model attracts the attention of practitioners of survival analysis.
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